Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia
NCT03186118
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
CD 19+ Acute Leukemia
Interventions
BIOLOGICAL:
T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC)
Sponsor
Seattle Children's Hospital